Correction: OPCML Is a Broad Tumor Suppressor for Multiple Carcinomas and Lymphomas with Frequently Epigenetic Inactivation

Correction: OPCML Is a Broad Tumor Suppressor for Multiple Carcinomas and Lymphomas with Frequently Epigenetic Inactivation

Bibliographic Details
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2008-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2556499/?tool=EBI

Similar Items

OPCML is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivation.
by: Yan Cui, et al.
Published: (2008-08-01)

TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma
by: Ma Ning, et al.
Published: (2010-11-01)

Epigenetic Inactivation of the Tumor Suppressor <i>IRX1</i> Occurs Frequently in Lung Adenocarcinoma and Its Silencing Is Associated with Impaired Prognosis
by: Miriam M. Küster, et al.
Published: (2020-11-01)

OPCML is hypermethylated in a subset of patients with metaplastic changes in their esophagus
by: Natalia Castaño-Rodríguez, et al.
Published: (2018-12-01)

Protocadherin 17 is a tumor suppressor and is frequently methylated in nasopharyngeal carcinoma
by: He Y, et al.
Published: (2019-02-01)

UTX is an escape from X-inactivation tumor-suppressor in B cell lymphoma
by: Xiaoxi Li, et al.
Published: (2018-07-01)

OPCML Methylation and the Risk of Ovarian Cancer: A Meta and Bioinformatics Analysis
by: Yang Shao, et al.
Published: (2021-03-01)

Protocadherin 17 Is a Tumor Suppressor and Is Frequently Methylated in Nasopharyngeal Carcinoma [Retraction]
by: He Y, et al.
Published: (2020-05-01)

Frequent down regulation of the tumor suppressor gene a20 in multiple myeloma.
by: Katharina Troppan, et al.
Published: (2015-01-01)

The Tumor Suppressive mir-148a Is Epigenetically Inactivated in Classical Hodgkin Lymphoma
by: Julia Paczkowska, et al.
Published: (2020-10-01)

NTRK3 is a potential tumor suppressor gene commonly inactivated by epigenetic mechanisms in colorectal cancer.
by: Yanxin Luo, et al.
Published: (2013-01-01)

Frequent epigenetic inactivation of <it>RASSF2 </it>in thyroid cancer and functional consequences
by: Hornung Juliane, et al.
Published: (2010-09-01)

Recurrent epigenetic silencing of the tumor suppressor in laryngeal squamous cell carcinoma
by: Marcin Szaumkessel, et al.
Published: (2017-02-01)

Epigenetic and genetic inactivation of tumor suppressor miR‐135a in non‐small‐cell lung cancer
by: Jin Eun Choi, et al.
Published: (2023-04-01)

OPCML, a novel systems regulator of tyrosine kinase signaling in ovarian and other cancers
by: Gabra H
Published: (2012-04-01)

ZAR1 is a novel epigenetically inactivated tumour suppressor in lung cancer
by: Antje M. Richter, et al.
Published: (2017-06-01)

<it>ECRG4 </it>is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and glioma
by: Kuhnen Cornelius, et al.
Published: (2009-12-01)

Impact of tumor suppressor genes inactivation on the multidrug resistance phenotype of hepatocellular carcinoma cells
by: Anabel Sanchez-Martin, et al.
Published: (2023-09-01)

Frequent Epigenetic Inactivation of DIRAS-1 and DIRAS-2 Contributes to Chemo-Resistance in Gliomas
by: Tanja Rothhammer-Hampl, et al.
Published: (2021-10-01)

Frequent and simultaneous epigenetic inactivation of TP53 pathway genes in acute lymphoblastic leukemia.
by: Amaia Vilas-Zornoza, et al.
Published: (2011-02-01)

Inactivation of the Hippo tumor suppressor pathway promotes melanoma
by: Marc A. Vittoria, et al.
Published: (2022-06-01)

Frequent alteration of the tumor suppressor gene APC in sporadic canine colorectal tumors.
by: Lydia Youmans, et al.
Published: (2012-01-01)

Epigenetic reactivation of tumor suppressor genes with CRISPRa technologies as precision therapy for hepatocellular carcinoma
by: Agustin Sgro, et al.
Published: (2023-04-01)

Inactivation of tumor suppressor TAp63 by hepatitis B virus X protein in hepatocellular carcinoma
by: Bangxiang Xie, et al.
Published: (2022-07-01)

Epigenetic inactivation of EFEMP1 is associated with tumor suppressive function in endometrial carcinoma.
by: Tingting Yang, et al.
Published: (2013-01-01)

The Schizophrenia Susceptibility Gene OPCML Regulates Spine Maturation and Cognitive Behaviors through Eph-Cofilin Signaling
by: Zhengrong Zhang, et al.
Published: (2019-10-01)

Down-regulated expression of OPCML predicts an unfavorable prognosis and promotes disease progression in human gastric cancer
by: Xiangbin Xing, et al.
Published: (2017-04-01)

Retinoblastoma Tumor Suppressor Protein Roles in Epigenetic Regulation
by: Frederick Guzman, et al.
Published: (2020-09-01)

Inactivation of Tumor Suppressor CYLD Inhibits Fibroblast Reprogramming to Pluripotency
by: Nikolaos Bekas, et al.
Published: (2023-10-01)

Epigenetic Silencing of Tumor Suppressor miR-124 Directly Supports STAT3 Activation in Cutaneous T-Cell Lymphoma
by: Lidia García-Colmenero, et al.
Published: (2020-12-01)

Tumor suppressor genes are frequently methylated in lymph node metastases of breast cancers
by: Xu Jia, et al.
Published: (2010-07-01)

Pathogenic Variants Associated with Epigenetic Control and the NOTCH Pathway Are Frequent in Classic Hodgkin Lymphoma
by: Antonio Santisteban-Espejo, et al.
Published: (2024-02-01)

SETD2, an epigenetic tumor suppressor: a focused review on GI tumor
by: Ming Hu, et al.
Published: (2020-01-01)

Roles of NRF3 in the Hallmarks of Cancer: Proteasomal Inactivation of Tumor Suppressors
by: Akira Kobayashi
Published: (2020-09-01)

Correction: Epigenetic silencing and tumor suppressor gene of HAND2 by targeting ERK signaling in colorectal cancer
by: Zixu Yuan, et al.
Published: (2022-07-01)

Significance of promoter methylation of multiple tumor suppressor genes in hepatocellular carcinoma
by: Alaa Tahoon, et al.
Published: (2022-02-01)

Epigenetic silencing of <it>MAL</it>, a putative tumor suppressor gene, can contribute to human epithelium cell carcinoma
by: Zhang Jun, et al.
Published: (2010-11-01)

Epigenetically inactivated RASSF1A as a tumor biomarker
by: Dora Raos, et al.
Published: (2021-08-01)

Promoterless Transposon Mutagenesis Drives Solid Cancers via Tumor Suppressor Inactivation
by: Aziz Aiderus, et al.
Published: (2021-01-01)

Hypoxia inactivates the VHL tumor suppressor through PIASy-mediated SUMO modification.
by: Qiliang Cai, et al.
Published: (2010-03-01)